Leaps by Bayer — Full Portfolio
8 tracked investments · listed companies and verified rows first
Dewpoint Therapeutics develops condensate-modulating drugs by using an integrated platform that maps, measures, and modulates biomolecular condensates to identify druggable targets and disease mechanisms.
AI & Machine LearningBiotechDeep TechBoston, US
Mark Murcko, Ph.D.(Director)Richard Young, Ph.D.(Director)Elisabeth Leiderman(Executive Officer)Ameet Nathwani, M.D.(Executive Officer, Director)Isaac Klein, M.D., Ph.D.(Executive Officer)Lori Escobedo(Executive Officer)
Soufflé Therapeutics develops nucleic acid medicines that precisely target and deliver genetic therapeutics to specific cell types to treat disease.
AI & Machine LearningBiotechDeep Tech
Victor Kotelianski(Founder)Daniel Anderson(Founder)Robert Langer(Founder)Marino Zerial(Founder)Brad Pentelute(Founder)Amir Nashat(Chief Executive Officer)
Apollo Agriculture provides financing, farm inputs, insurance, and agricultural training to smallholder farmers, using machine learning credit models to make instant lending decisions.
AgTechAI & Machine LearningFintechOakland, US
Earl Joseph St. Sauver(Director)Seth Todd Silverman(Director)Eli John Pollak(Executive Officer, Director)Eli Pollak(Co-founder & CEO)Benjamin Njenga(Co-founder)Earl St Sauver(Co-founder)
Fork & Good develops cultivated meat technology using a hydroponic system approach that integrates cell biology with farming principles to produce real meat from cells at scale.
BiotechDeep TechFoodTechNutley, US
Gabor Forgacs(Chief Scientific Officer and co-founder)Andras Forgacs(Partner and co-founder)Niya Sharma(Co-founder)Niyati Gupta(Executive Officer, Director)Lauren Loktev(Director)
Immunitas discovers and develops therapeutic antibodies for cancer and autoimmune diseases, with its lead program targeting CD161 for solid tumors and hematological malignancies.
BiotechDigital HealthMedical DevicesWaltham, US
Amanda Wagner(Executive Officer)Dan Matloff(Executive Officer)Jiaping Gu(Director)Jeffrey Goldberg(Executive Officer, Director)Juergen Eckhardt(Director)
BoardLaura Brass(Director)
NextPoint is developing precision cancer therapeutics based on the B7-H7/HHLA2 axis, including T-cell engagers, antibody-drug conjugates, and checkpoint inhibitors for cancer patients.
BiotechDigital HealthMedical DevicesAustin, US
Ivan Cheung(Executive Officer, Director)Axel Hoos(Director)Jeffrey Lacey(Executive Officer)
BoardDetlev Biniszkiewicz(Director)R. Jacob Vogelstein(Director)Brian Shuster(Director)
One.bio develops food products designed to provide beneficial molecular signals to support health and address chronic inflammatory disease.
BiotechFoodTechHealthtechWellness & Fitness
Matt Amicucci(Co-Founder & Chief Science Officer)Matt Barnard(Co-Founder & CEO)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.